Call for action on medicine access in developing countries Media release 02 February 2013 Pages: 2 - 2
Adjuvant trastuzumab promising but costly for breast cancer Clinical study 02 February 2013 Pages: 3 - 3
Pemetrexed + cisplatin benefits worth costs in mesothelioma Clinical study 02 February 2013 Pages: 3 - 3
Rabies vax in children more costly than canine control in Thailand Clinical study 02 February 2013 Pages: 4 - 4
Budesonide + salbutamol cost effective for asthma in Thailand Clinical study 02 February 2013 Pages: 5 - 5
PUVA, ciclosporin, or methotrexate best value for severe psoriasis Clinical study 02 February 2013 Pages: 5 - 5
Nevirapine regimens best value for mother-to-child HIV prevention News item 02 February 2013 Pages: 6 - 6
Paclitaxel-eluting stent cost effective in high-risk patients in Sweden Media release 02 February 2013 Pages: 8 - 8
Desloratadine breathes QOL into seasonal allergic rhinitis Clinical study 02 February 2013 Pages: 9 - 9
Antiretroviral access increased but still room for improvement News item 02 February 2013 Pages: 10 - 10